Synapse Medicine
Synapse Medicine builds an AI-powered medication intelligence platform delivered via APIs and React Native components to EHR, e-prescribing, and telehealth software vendors, as well as directly to hospitals. The platform serves 400,000+ healthcare professionals and 150,000+ doctors via MedGPT.fr across France, the US, Europe, and Asia.
- Company typePrivate
- Founded2017
- HeadquartersBordeaux, France
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Synapse Medicine does
Synapse Medicine is a French healthtech company founded in 2017 that builds an AI-powered medication intelligence platform for healthcare professionals and software vendors. Headquartered in Bordeaux with offices in Paris, New York, and coworking locations in Lacanau and Montalivet, the company develops a knowledge-graph-architecture platform that aggregates heterogeneous drug data from official sources, including the 40-year-old Thériaque certified drug database. Its product portfolio includes Synapse Database (multi-source drug information), Synapse Secure (CE Class IIb-certified prescription safety), Synapse Copilote (an AI suite with voice, clinical follow-up, and prescription optimization modules), Synapse Prescribe (ONC-certified for the US market), and sub-brands MedGPT.fr (a generative AI medical assistant used by 150,000+ doctors in France) and Goodmed (a patient-facing app).
The underlying technology combines a proprietary knowledge graph and Synapse ontology with internally developed NLP, OCR, and recommendation algorithms, and uses Mistral LLMs for generative AI features. The platform is delivered as APIs and React Native front-end components that integrate into EHR, e-prescribing, and telehealth software, with 60+ vendor integrations completed and 400,000+ healthcare professionals reached across France, the US, Europe, and Asia. Synapse Medicine holds CE Class IIb, ISO 13485, ONC Certified Health IT, and HAS LAP/LAD certifications.
Synapse Medicine operates a B2B subscription revenue model combining direct enterprise sales to hospitals and large healthcare organizations with OEM/embedded licensing of APIs and React Native components to healthcare software vendors. Pricing is quote-based and not publicly disclosed. The go-to-market motion pairs enterprise field sales (particularly for large hospital systems and EHR publishers) with an API-first, developer-friendly integration approach. The company has raised approximately €35-40M across three funding rounds (seed 2019, Series A 2020, Series B 2022 led by Korelya Capital), with investors including XAnge, BNP Paribas Développement, MACSF, and Mutuelles Impact.
Synapse Medicine firmographics
Firmographics- Name
- Synapse Medicine
- Legal name
- Synapse Medicine
- Website
- https://synapse-medicine.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Synapse Medicine builds an AI-powered medication intelligence platform delivered via APIs and React Native components to EHR, e-prescribing, and telehealth software vendors, as well as directly to hospitals. The platform serves 400,000+ healthcare professionals and 150,000+ doctors via MedGPT.fr across France, the US, Europe, and Asia.
- Ownership category
- akta.pro rank
Synapse Medicine industry classification
Industry- Product category
- Clinical Decision Support Software
- NAICS
- Computer Systems Design and Related Services (54151)
- SIC
- Services-Prepackaged Software (7372), Services-Health Services (8000)
- akta.pro primary industry
- Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)
Keywords
Where Synapse Medicine is headquartered
LocationHeadquarters
- HQ city
- Bordeaux
- HQ country
- France
- HQ region
- Europe
Offices5 records
Markets served
Synapse Medicine business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Others
Revenue model
- API and Component Licensing: Revenue generated from licensing clinical decision support APIs and customizable React Native components to healthcare software vendors (EHR, e-prescribing platforms). Software publishers integrate Synapse widgets and pay for usage based on API calls or component deployments.
- Enterprise Software Subscriptions: Direct sales to hospitals and healthcare organizations for prescription safety solutions. Complete suite of clinical decision support APIs and customizable front-end components.
- Synapse Database: Multi-source reliable drug database providing coverage of health products for international expansion
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise deployment with full API access and component suite |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
Synapse Medicine product offering
Product offeringCore offering
Synapse Medicine develops a medication intelligence platform that provides clinical decision support APIs and React Native components for healthcare software vendors and providers. The platform aggregates official drug databases and uses AI to power prescription safety, drug interaction analysis, dosage verification, and personalized clinical recommendations. It is delivered as embeddable software integrated into EHR and e-prescribing systems, certified as a CE Class IIb medical device in Europe and ONC Certified Health IT in the US.
Product overview
Synapse Medicine offers a modular medication intelligence platform composed of three core products: Synapse Database (multi-source drug information), Synapse Secure (prescription safety with CE Class IIb medical device certification), and Synapse Copilote (AI-powered clinical decision support suite including voice assistant, prescription optimizer, and clinical follow-up tools). The platform is available as APIs and React Native components for EHR integration, serving over 400,000 healthcare professionals across France, the US, Europe, and Asia. Key sub-brands include MedGPT.fr (generative AI for 150,000+ doctors) and Goodmed (patient-facing app). The company also offers numerous clinical widgets (dosage analysis, drug interactions, adverse effects, pathology/allergy search, geriatric recommendations) and a pharmacovigilance module (Medication Shield), all integrated via a unified API architecture.
Differentiator
Problem solved
Functional benefit
Brands
- MedGPT: Generative AI medical assistant for healthcare professionals, the first French medical AI dedicated to healthcare professionals, available at medgpt.fr
- Goodmed
Products and services
- Synapse Copilote
Quantifiable outcome
- 400,000+ healthcare professionals using the platform
- +4 more outcomes
Companies that use Synapse Medicine
Customer profileNamed customers9 records
Segments5 records
Ideal customer profiles4 records
Synapse Medicine technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability7 records
Feature8 records
Synapse Medicine partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered key partner, integration partner, core data partner, government partner, research partner and clinical partner.
- CGMkey partnerIntegration of Synapse Medicine's clinical decision support into CGM's e-prescribing software for European market. CGM is a major healthcare software provider.
- Hellocareintegration partnerAPI and component integration into Hellocare telehealth platform to enable safer prescribing within their solution.
- Lifenintegration partnerPartnership extending interoperability to medication reconciliation and medication management on the Lifen Platform for improved patient care.
- Thériaquecore data partner40-year-old certified drug database, one of 5 databases approved by HAS (French health authority). Thériaque provides the foundational drug information for Synapse's platform.
- ANSM (Agence nationale de sécurité du médicament)government partnerFrench medicines agency partnership for automatic annotation of adverse event reports during COVID-19 vaccination campaign. Module analyzing daily patient treatment reports.
- Brigham and Women's Hospitalresearch partnerHealthcare research partnership for trusted drug information access initiatives.
- Gustave Roussyclinical partnerMajor French cancer center partnership for medication intelligence platform deployment.
- Harvard Universityresearch partnerAcademic partnership for healthcare innovation research collaboration.
- Vanderbilt Universityresearch partnerAcademic research partnership for healthcare technology innovation.
- Tokyo Metropolitan Governmentgovernment partnerPartnership for drug information platform deployment in Japan, supporting international expansion.
Scale indicators8 records
Recent moves7 records
Expansion highlights6 records
Synapse Medicine competitors and assessment
Company assessmentBroad incumbents
- Wolters Kluwer (Lexicomp / Medi-Span / UpToDate): Wolters Kluwer is a large incumbent in drug information and clinical decision support, with Lexicomp and Medi-Span providing the same core capabilities as Synapse Medicine (drug interaction checking, dosage analysis, monographs) sold into hospitals, EHR vendors, and pharmacies. Comparable because it competes head-to-head in medication-decision support at enterprise scale.
- Elsevier (ClinicalKey / Gold Standard Drug Database): Elsevier's Clinical Pharmacology and Gold Standard Drug Database compete directly with Synapse Database and Synapse Secure, providing drug monographs, interaction analysis, and clinical decision support to hospitals and EHR platforms. Comparable as an established content-and-CDS vendor with broad hospital penetration.
- Epic Systems (CDS modules): Epic's Best Care Alert and embedded CDS modules include medication interaction and dosing alerts that compete with Synapse's offering for hospitals running Epic. While Epic is primarily an EHR vendor, its native CDS capabilities are a direct substitute and a channel consideration for Synapse's OEM strategy.
- UpToDate (Wolters Kluwer): UpToDate is a leading evidence-based clinical decision support resource used by clinicians at the point of care, including drug therapy recommendations. While broader than medication-specific CDS, it overlaps with Synapse Copilot Follow and MedGPT.fr as an AI-adjacent knowledge resource for prescribers.
Direct peers
- First Databank (FDB): First Databank provides drug knowledge bases and clinical decision support modules embedded in EHRs and pharmacy systems, including medication screening, interaction checking, and dosing guidance - the same product surface area as Synapse Secure and Synapse Copilote. Highly comparable as a specialized CDS content and software vendor.
- DrFirst: DrFirst delivers e-prescribing, medication management, and clinical decision support APIs to hospitals and EHR vendors, with similar OEM/embedded distribution model as Synapse Medicine. Comparable in both product scope and go-to-market approach targeting healthcare software publishers.
- RxRevu (CoverMyMeds): RxRevu, now part of CoverMyMeds/McKesson, provides prescription decision support and real-time benefit check APIs integrated into EHR workflows - directly comparable to Synapse Prescribe and Synapse Copilote for medication decision support at the point of prescribing.
- CGM (CompuGroup Medical): CGM is both a partner and a comparable peer: it is a leading e-prescribing and practice management software vendor in Europe that has integrated Synapse's CDS but also operates its own clinical decision capabilities. Comparable as an e-prescribing/medication software vendor with hospital and physician footprint in Europe.
Emerging players
- HelloCare: HelloCare is a telehealth platform that has integrated Synapse Medicine's API and components for safer prescribing. While smaller and more regionally focused, it is comparable as a clinical-software customer/partnership case study in the same digital health segment.
Others
- Surescripts: Surescripts is the dominant US e-prescribing network, and Synapse Prescribe's ONC certification explicitly relies upon Surescripts software. While not a direct competitor in CDS, it is a critical infrastructure provider and adjacent ecosystem participant relevant to Synapse's US distribution.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Synapse Medicine social profiles
Digital presenceSynapse Medicine compliance and trust
Trust signalCompliance4 records
Synapse Medicine financial estimates
Financial estimateRevenue estimate
Valuation estimate
Synapse Medicine leadership team
Management profileNumber of profiles
Profiles8 records
Synapse Medicine subsidiaries and ownership
Company hierarchySubsidiaries1 record
Synapse Medicine funding detail
Funding detailFunding overview
Funding rounds3 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Synapse Medicine M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Synapse Medicine
What does Synapse Medicine do?
Synapse Medicine develops a medication intelligence platform that provides clinical decision support APIs and React Native components for healthcare software vendors and providers. The platform aggregates official drug databases and uses AI to power prescription safety, drug interaction analysis, dosage verification, and personalized clinical recommendations. It is delivered as embeddable software integrated into EHR and e-prescribing systems, certified as a CE Class IIb medical device in Europe and ONC Certified Health IT in the US.
Is Synapse Medicine a public or private company?
Synapse Medicine is a private company. It is classified as venture growth investor backed and is currently operating.
When was Synapse Medicine founded?
Synapse Medicine was founded in 2017. It employs 51 to 100 people.
Where is Synapse Medicine based?
Synapse Medicine is headquartered in Bordeaux, France, in the Europe region.
How does Synapse Medicine make money?
Three revenue lines are on record. API and Component Licensing is the primary driver. The others are enterprise Software Subscriptions and synapse Database.
Who are Synapse Medicine's main competitors?
Broad incumbents on record are Wolters Kluwer (Lexicomp / Medi-Span / UpToDate), Elsevier (ClinicalKey / Gold Standard Drug Database), Epic Systems (CDS modules) and UpToDate (Wolters Kluwer). Direct peers are First Databank (FDB), DrFirst, RxRevu (CoverMyMeds) and CGM (CompuGroup Medical). HelloCare is listed as an emerging player. Surescripts is listed as an others.
Does Synapse Medicine have an API?
Yes. Synapse Medicine offers a complete suite of clinical decision support APIs and customizable front-end components built with React Native that integrate seamlessly into EHR, e-prescribing software, or clinical workflows. The API provides drug information, clinical decision support, prescription analysis, and medication safety features. Access is via authentication at auth.us.synapse-medicine.com/realms/integrator/login-actions/authenticate?client_id=oauth2-proxy. Developer documentation is at auth.us.synapse-medicine.com/realms/integrator/login-actions/authenticate?client_id=oauth2-proxy&tab_id=rbsI3hH6xds.
What industry is Synapse Medicine in?
Synapse Medicine's product category is Clinical Decision Support Software. Its primary akta.pro industry code is HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms. Its NAICS code is 54151 and its SIC code is 7372.